pipette
ENEnglish

ZNF683-positive tissue-resident memory T cells organize treatment-refractory niches with targetable circuits in inclusion body myositis

F. V. A. De Los Reyes, S. Hayashi, M. Kato, J. Tanboon, S. Noguchi, I. Nishino

Preprint

En palabras de los autores

Inclusion body myositis (IBM) is a progressive autoimmune myositis refractory to conventional immunosuppression, yet mechanisms sustaining chronic inflammation remain unresolved. Integrating comparative single-nucleus RNA sequencing, spatial transcriptomics, and orthogonal validation across autoimmune myositis, we identified ZNF683+IL7R+ cytotoxic tissue-resident memory T (TRM) cells with natural killer cell-like features enriched in IBM. Trajectory analysis positioned an early-disease ZBTB16+ cytotoxic T cell state upstream of ZNF683+IL7R+TRM. ZNF683 overexpression induced memory and natural killer cell-like transcriptional programs while attenuating glucocorticoid-response signatures, linking this program to treatment refractoriness. Ligand-receptor modeling nominated candidate targetable circuits involving IL-15-IL15RA, XCL1-XCR1, and HMGB1/CXCL12-CXCR4. Spatial transcriptomics localized ZNF683+TRM to stress-associated IBM niches. These findings define a disease-specific TRM-centered circuit linked to treatment refractoriness and candidate therapeutic vulnerabilities in IBM.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 18 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.11.16.26367991